Lev Becker to CD8-Positive T-Lymphocytes
This is a "connection" page, showing publications Lev Becker has written about CD8-Positive T-Lymphocytes.
Connection Strength
0.417
-
Developing a therapeutic elastase that stimulates anti-tumor immunity by selectively killing cancer cells. Cell Rep Med. 2025 Nov 18; 6(11):102446.
Score: 0.168
-
A lysosome-targeted DNA nanodevice selectively targets macrophages to attenuate tumours. Nat Nanotechnol. 2021 12; 16(12):1394-1402.
Score: 0.127
-
Neutrophil elastase selectively kills cancer cells and attenuates tumorigenesis. Cell. 2021 06 10; 184(12):3163-3177.e21.
Score: 0.123